Cargando…

2377. Social Determinants Impact Readmission Following Clostridioides difficile-Related Index Hospital Stay in Medicare Patients

BACKGROUND: Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated diarrhea and recurs in up to 30% of patients, often requiring readmission. Socioeconomic factors, such as living in a disadvantaged neighborhood may impact readmission but have not been studied. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scaria, Elizabeth, Powell, Ryan, Birstler, Jen, Alagoz, Oguzhan, Shirley, Daniel, Safdar, Nasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809797/ http://dx.doi.org/10.1093/ofid/ofz360.2055

Ejemplares similares

Neighborhood disadvantage and 30-day readmission risk following Clostridioides difficile infection hospitalization
por: Scaria, Elizabeth, et al.
Publicado: (2020)

Validating agent-based simulation model of hospital-associated Clostridioides difficile infection using primary hospital data
por: Scaria, Elizabeth, et al.
Publicado: (2023)

Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection
por: Barker, Anna K., et al.
Publicado: (2020)

2418. Determining the Impact of Visitor Contact Precautions on Hospital-Onset Clostridioides difficile Infection Rates: An Agent-Based Simulation Modeling Approach
por: Alagoz, Oguzhan, et al.
Publicado: (2019)

Association of Visitor Contact Precautions With Estimated Hospital-Onset Clostridioides difficile Infection Rates in Acute Care Hospitals
por: Scaria, Elizabeth, et al.
Publicado: (2021)

2423. Cost-effectiveness of core and emerging infection control interventions to reduce hospital-onset Clostridioides difficile infection: An agent-based simulation modeling approach
por: Alagoz, Oguzhan, et al.
Publicado: (2019)

534. Clostridium difficile Reduction: An Agent-Based Simulation Modeling Approach to Evaluating Intervention Comparative Effectiveness at Pediatric Hospitals
por: Barker, Anna, et al.
Publicado: (2018)

The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2022)

Treatment issues in recurrent Clostridioides difficile infections and the possible role of germinants
por: Budi, Noah, et al.
Publicado: (2020)

Negative interactions determine Clostridioides difficile growth in synthetic human gut communities
por: Hromada, Susan, et al.
Publicado: (2021)

Clinical Characteristics and Fecal Microbiome in Recurrent Versus Nonrecurrent Clostridioides difficile Infection
por: Lanjewar, Swapnil, et al.
Publicado: (2021)

1037. Efficacy of Germinants and Omadacycline for Preventing Clostridioides difficile Relapse in a Murine Model
por: Budi, Noah, et al.
Publicado: (2021)

Efficacy of Omadacycline or Vancomycin Combined With Germinants for Preventing Clostridioides difficile Relapse in a Murine Model
por: Budi, Noah D, et al.
Publicado: (2022)

Medicare's hospital readmissions reduction program and the rise in observation stays
por: Wright, Brad, et al.
Publicado: (2023)

Trend of Hospital Readmissions, Mortality, ER Visits and Observation Room Stays in Clostridium difficile Infection Cases in Medicare Advantage Population
por: Bhattacharjee, Reshma, et al.
Publicado: (2014)

The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach
por: Alagoz, Oguzhan, et al.
Publicado: (2021)

Decreasing ICU-associated Clostridioides difficile infection through fluoroquinolone restriction, the FIRST trial: a study protocol
por: Safdar, Nasia, et al.
Publicado: (2021)

Accounting for the Growth of Observation Stays in the Assessment of Medicare’s Hospital Readmissions Reduction Program
por: Sabbatini, Amber K., et al.
Publicado: (2022)

2376. Incidence of Clostridioides difficile Infection Among United States Medicare Advantage Enrollees
por: Heinrich, Kirstin, et al.
Publicado: (2019)

2394. A Longitudinal Study of the Effect of Renal Failure on Readmission Rates of Patients with Clostridioides difficile
por: Destache, Christopher J, et al.
Publicado: (2019)

Risk Factors for Hospital Readmission for Clostridioides difficile Infection: A Statewide Retrospective Cohort Study
por: Benitez, Gregorio, et al.
Publicado: (2022)

Mortality, Hospital Costs, Payments, and Readmissions Associated With Clostridium difficile Infection Among Medicare Beneficiaries
por: Drozd, Edward M., et al.
Publicado: (2015)

Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with Clostridioides difficile infection with and without sepsis
por: Amin, Alpesh, et al.
Publicado: (2022)

Clinical burden of recurrent Clostridioides difficile infection in the medicare population: A real-world claims analysis
por: Feuerstadt, Paul, et al.
Publicado: (2022)

381. Antibiotic Spectrum Index and Risk of Clostridioides difficile Infection
por: Ray, Michael J, et al.
Publicado: (2022)

780. How Much Does Prior Hospitalization Contribute to Readmission with Community-onset Clostridioides difficile Infection?
por: Guh, Alice, et al.
Publicado: (2020)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Impact of Timing of and Adherence to Social Distancing Measures on COVID-19 Burden in the US: A Simulation Modeling Approach
por: Alagoz, Oguzhan, et al.
Publicado: (2020)

Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2022)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Iron Effects on Clostridioides difficile Toxin Production and Antimicrobial Susceptibilities
por: Yamaki, Jason, et al.
Publicado: (2022)

16. Attributable Mortality, Healthcare Costs and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2021)

Clostridioides difficile infection: curbing a difficult menace
por: Khanna, Sahil, et al.
Publicado: (2022)

Association between Medicare’s Hospital Readmission Reduction Program and readmission rates across hospitals by medicare bed share
por: Banerjee, Souvik, et al.
Publicado: (2021)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

Identification of Clostridioides difficile-Inhibiting Gut Commensals Using Culturomics, Phenotyping, and Combinatorial Community Assembly
por: Ghimire, Sudeep, et al.
Publicado: (2020)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

2377. The Influence of the COVID-19 Infodemic on Vaccine Hesitancy: A Prospective Survey-Based Study
por: Quon, Cameron, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jk38pu972uf53icr315tbb0v50